These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 358658)
1. [Action of the anti-inflammatory agent Lonazolac on experimentally-induced acute inflammation of human skin]. Dethlefs J Z Rheumatol; 1978; 37(7-8):254-9. PubMed ID: 358658 [TBL] [Abstract][Full Text] [Related]
2. [Lonazolac-Ca-a non-steroidal antirheumatic agent. Long-term clinical study in chronic polyarthritis]. Lonauer G; Wagner H; Boerngen U; Goebel KM Z Rheumatol; 1981; 40(4):161-4. PubMed ID: 7027681 [TBL] [Abstract][Full Text] [Related]
3. Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis. Seghezzi R; Borri P; Chierichetti S; Ferrari P Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:272-4. PubMed ID: 4553236 [No Abstract] [Full Text] [Related]
5. Therapy with irritren in rheumatic degenerative diseases. Georgescu C; Dumitrescu C; Dănău M; Spandonidis S; Costache G Med Interne; 1986; 24(2):147-51. PubMed ID: 3487823 [TBL] [Abstract][Full Text] [Related]
6. [Lonazolac - a new non-steroidal antirheumatic agent. Report of a double-blind crossover clinical study]. Trnavský K; Bosmanský K Fysiatr Revmatol Vestn; 1983 Jun; 61(3):147-52. PubMed ID: 6350135 [No Abstract] [Full Text] [Related]
7. Preliminary double-blind evaluation of a new, non-steroidal anti-inflammatory drug: protacine. Münzenberg J; Tachibana S Pharmatherapeutica; 1980; 2(5):279-84. PubMed ID: 7001486 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacology of a new potential anti-inflammatory drug, 1-(3',4'-methylenedioxybenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid (ID-955). Yamamoto H; Saito C; Okamoto T; Awata H; Inukai T; Hirohashi A; Yukawa Y Arzneimittelforschung; 1969 Jun; 19(6):981-4. PubMed ID: 5820043 [No Abstract] [Full Text] [Related]
9. 4-nitro-2-phenoxymethanesulfonanilide (R-805): a chemically novel anti-inflammatory agent. Swingle KF; Moore GG; Grant TJ Arch Int Pharmacodyn Ther; 1976 May; 221(1):132-9. PubMed ID: 962423 [TBL] [Abstract][Full Text] [Related]
10. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity. Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053 [TBL] [Abstract][Full Text] [Related]
11. [Further contributions on the therapeutic action of Febutol in ORL]. Perrella F; Alinei D Minerva Otorinolaringol; 1968; 18(2):94-8. PubMed ID: 5741565 [No Abstract] [Full Text] [Related]
12. Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation. Nezić L; Skrbić R; Dobrić S; Stojiljković MP; Jaćević V; Satara SS; Milovanović ZA; Stojaković N Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):185-91. PubMed ID: 19210496 [TBL] [Abstract][Full Text] [Related]
13. [Measuring techniques and clinical testing of an anti-inflammatory agent (tantum)]. Gabka J; Matsumura T Munch Med Wochenschr; 1971 Feb; 113(6):198-203. PubMed ID: 4925048 [No Abstract] [Full Text] [Related]
14. [Lonazolac-Calcium. A new non-steroidal antirheumatic agent for the treatment of progressive polyarthritis. A long-term open controlled trial]. Pavelka K Fysiatr Revmatol Vestn; 1984 Apr; 62(2):80-7. PubMed ID: 6378745 [No Abstract] [Full Text] [Related]